ABVX (Abivax) Other Operating Expense : $-5.02 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Abivax Other Operating Expense?

Abivax's Other Operating Expense for the six months ended in Dec. 2023 was $-2.55 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.02 Mil.

Abivax's quarterly Other Operating Expense increased from Dec. 2022 ($-39.46 Mil) to Jun. 2023 ($-2.47 Mil) but then declined from Jun. 2023 ($-2.47 Mil) to Dec. 2023 ($-2.55 Mil).

Abivax's annual Other Operating Expense increased from Dec. 2021 ($-64.95 Mil) to Dec. 2022 ($-58.63 Mil) and increased from Dec. 2022 ($-58.63 Mil) to Dec. 2023 ($-5.04 Mil).

Abivax Other Operating Expense Historical Data

The historical data trend for Abivax's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abivax Other Operating Expense Chart

Abivax Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

0.24

-1.67

-64.95

-58.63

-5.04

Abivax Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-0.33	-19.13	-39.46	-2.47	-2.55

Abivax Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-5.02 Mil.

Abivax Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Abivax's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Abivax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (NAS:ABVX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

0RA9:UK ABVX:France 2X1:Germany

Address

7-11 boulevard Haussmann, Paris, FRA, 75009

Website

https://www.abivax.com

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.